Get access to the webinar:
Specialty Excipients in Parenteral Pharmaceuticals
Introduction to speaker and topics
Driven by an increasing number of large biologics and poorly soluble APIs, the market for specialty parenteral excipients in the United States and Europe has reached USD 0.5 billion and is expected to grow at 8% through 2021.
From this webinar, you'll learn about:
Market size of specialty parenteral excipients in each region by type
of formulation, function, and excipient
Inter-product competition and the most favored excipients
Market forecasts through 2021
About the Presenter
 |
Shilpi MehrotraProject Manager, Chemicals & Materials Practice at Kline & Company |
Country coverage
United States and Europe
Type of formulation
Lyophilization, liquid solutions, and pharmaceutical suspension
Excipient coverage
Over 20 specialty excipients, including dextrose, NaCl, trehalose and more
Submit the form below to get access to this webinar
Submit the form below to get access to this webinar
About Kline Group
Kline is a respected provider of world-class consulting services and high-quality market intelligence that consistently lead to client successes in growing or improving their business.
We combine a distinctive package of consulting and research capabilities, global reach, and industry understanding that cannot be matched by our competitors. Our focus is on providing knowledge and solutions throughout the entire value chains of the industries we serve.